Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 15;29(8):1355-64.
doi: 10.1021/acs.chemrestox.6b00193. Epub 2016 Aug 3.

Phospholipid Ozonation Products Activate the 5-Lipoxygenase Pathway in Macrophages

Affiliations

Phospholipid Ozonation Products Activate the 5-Lipoxygenase Pathway in Macrophages

Karin A Zemski Berry et al. Chem Res Toxicol. .

Abstract

Ozone is a highly reactive environmental toxicant that can react with the double bonds of lipids in pulmonary surfactant. This study was undertaken to investigate the proinflammatory properties of the major lipid-ozone product in pulmonary surfactant, 1-palmitoyl-2-(9'-oxo-nonanoyl)-glycerophosphocholine (16:0/9al-PC), with respect to eicosanoid production. A dose-dependent increase in the formation of 5-lipoxygenase (5-LO) products was observed in murine resident peritoneal macrophages (RPM) and alveolar macrophages (AM) upon treatment with 16:0/9al-PC. In contrast, the production of cyclooxygenase (COX) derived eicosanoids did not change from basal levels in the presence of 16:0/9al-PC. When 16:0/9al-PC and the TLR2 ligand, zymosan, were added to RPM or AM, an enhancement of 5-LO product formation along with a concomitant decrease in COX product formation was observed. Neither intracellular calcium levels nor arachidonic acid release was influenced by the addition of 16:0/9al-PC to RPM. Results from mitogen-activated protein kinase (MAPK) inhibitor studies and direct measurement of phosphorylation of MAPKs revealed that 16:0/9al-PC activates the p38 MAPK pathway in RPM, which results in the activation of 5-LO. Our results indicate that 16:0/9al-PC has a profound effect on the eicosanoid pathway, which may have implications in inflammatory pulmonary disease states where eicosanoids have been shown to play a role.

PubMed Disclaimer

Figures

Figure 1
Figure 1. 16:0/9al-PC activates the 5-LO pathway in resident peritoneal macrophages
Dose response of the production of A) 5-LO products (LTC4, 6-trans-LTB4, LTB4, and 5-HETE) and B) COX products (PGE2 and TXB2) with the addition of 16:0/9al-PC (closed squares) and POPC (closed triangles) to RPM for 1h at 37°C. The insets show the amounts of each individual 5-LO metabolite (LTC4, 6-trans-LTB4, LTB4, and 5-HETE) and COX metabolite (PGE2 and TXB2) produced with 75 µM 16:0/9al-PC treatment. After incubation, the eicosanoids (LTC4, 6-trans-LTB4, LTB4, 5-HETE, PGE2, and TXB2) were analyzed by LC-MS/MS and quantified using standard isotope dilution. Results shown are averages ± SEM (n=3) from three independent experiments. * p< 0.05; ** p<0.01; *** p<0.0001.
Figure 2
Figure 2. 16:0/9al-PC influences eicosanoid production in zymosan treated resident peritoneal macrophages
Dose response of the production of A) 5-LO products (LTC4, 6-trans-LTB4, LTB4, and 5-HETE) and B) COX products (PGE2 and TXB2) with the addition of 16:0/9al-PC (closed squares) and POPC (closed triangles) for 3 min followed by the addition of zymosan (25 particles per cell) to resident peritoneal macrophages for 1h at 37°C. After incubation, the eicosanoids (LTC4, 6-trans-LTB4, LTB4, 5-HETE, PGE2, and TXB2) were analyzed by LC-MS/MS and quantified using standard isotope dilution. Results shown are averages ± SEM (n=3) from three independent experiments. * p< 0.05; ** p<0.01; *** p<0.0001.
Figure 3
Figure 3. Effect of MAPK inhibitors on the production of 5-LO products in resident peritoneal macrophages
RPM were pre-incubated with the MAPK inhibitors (10 µM), SB202190 (SB; p38 MAPK inhibitor), U0126 (U; MEK/ERK inhibitor), and SP600125 (SP; JNK inhibitor), or vehicle control for 30 min and then stimulated with A) 16:0/9al-PC (37.5 µM) and B) 16:0/9al-PC (37.5 µM) and zymosan (25 particles/cell) for 1h. After incubation, the 5-LO-derived eicosanoids (LTC4, 6-trans-LTB4, LTB4, and 5-HETE) were analyzed by LC-MS/MS and quantified using standard isotope dilution. Results shown are averages ± SEM (n=3) from three independent experiments. * p< 0.05; ** p<0.01; *** p<0.0001.
Figure 4
Figure 4. 16:0/9al-PC induces phosphorylation of p38 in resident peritoneal macrophages
RPM were treated with zymosan (25 particles/cell), 16:0/9al-PC (37.5 µM), or 16:0/9al-PC (37.5 µM) and zymosan (25 particles/cell) for 30 min. A) Cell lysates were collected and analyzed by Western blotting with antibodies to phosphorylated forms of p38 and ERK1/2 and β-actin to normalize for equal loading. The data in this figure are representative of 3 independent experiments. The optical densities measured for the control samples were set as 100% and the results shown for B) phospho-p38 and C) phospho-ERK1/2 are averages ± SEM (n=3) from three independent experiments. * p< 0.05; ** p<0.01; *** p<0.0001.

References

    1. Pryor WA. How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radic. Biol. Med. 1992;12:83–88. - PubMed
    1. Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic. Biol. Med. 1995;19:935–941. - PubMed
    1. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1993;147:218–233. - PubMed
    1. Uhlson C, Harrison K, Allen CB, Ahmad S, White CW, Murphy RC. Oxidized phospholipids derived from ozone-treated lung surfactant extract reduce macrophage and epithelial cell viability. Chem. Res. Toxicol. 2002;15:896–906. - PubMed
    1. Almstrand A-C, Voelker D, Murphy RC. Identification of oxidized phospholipids in bronchoalveolar lavage exposed to low ozone levels using multivariate analysis. Anal. Biochem. 2015;474:50–58. - PMC - PubMed

Publication types